Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000874015-25-000119
Filing Date
2025-04-17
Accepted
2025-04-17 16:53:18
Documents
1
Period of Report
2025-04-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 7912
  Complete submission text file 0000874015-25-000119.txt   9436
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Issuer) CIK: 0000874015 (see all company filings)

EIN.: 330336973 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AKCEA THERAPEUTICS, INC. 22 BOSTON WHARF ROAD, 9TH FLOOR BOSTON MA 02210
Business Address
Jenne Kyle (Reporting) CIK: 0001791857 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19125 | Film No.: 25848026